BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 32256950)

  • 1. Advanced Glycation End Products (AGEs): Biochemistry, Signaling, Analytical Methods, and Epigenetic Effects.
    Perrone A; Giovino A; Benny J; Martinelli F
    Oxid Med Cell Longev; 2020; 2020():3818196. PubMed ID: 32256950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Methods for measuring the protein glycation products formed in the human organism].
    Staniszewska M; Gamian A
    Postepy Hig Med Dosw; 2003; 57(4):359-68. PubMed ID: 14601248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical/Translational Aspects of Advanced Glycation End-Products.
    Zeng C; Li Y; Ma J; Niu L; Tay FR
    Trends Endocrinol Metab; 2019 Dec; 30(12):959-973. PubMed ID: 31597608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end products (AGEs) and cardiovascular dysfunction: focus on high molecular weight AGEs.
    Deluyker D; Evens L; Bito V
    Amino Acids; 2017 Sep; 49(9):1535-1541. PubMed ID: 28710551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions.
    Neviere R; Yu Y; Wang L; Tessier F; Boulanger E
    Glycoconj J; 2016 Aug; 33(4):607-17. PubMed ID: 27277623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced Glycation End Products (AGEs), Glutathione and Breast Cancer: Factors, Mechanism and Therapeutic Interventions.
    Sharma AK; Sharma VR; Gupta GK; Ashraf GM; Kamal MA
    Curr Drug Metab; 2019; 20(1):65-71. PubMed ID: 30207227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end products as biomarkers in systemic diseases: premises and perspectives of salivary advanced glycation end products.
    Băbţan AM; Ilea A; Boşca BA; Crişan M; Petrescu NB; Collino M; Sainz RM; Gerlach JQ; Câmpian RS
    Biomark Med; 2019 Apr; 13(6):479-495. PubMed ID: 30968701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-based detection of advanced glycation end-products: promises vs. limitations.
    Nagai R; Shirakawa J; Ohno R; Hatano K; Sugawa H; Arakawa S; Ichimaru K; Kinoshita S; Sakata N; Nagai M
    Glycoconj J; 2016 Aug; 33(4):545-52. PubMed ID: 27421861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end products (AGEs) in oral pathology.
    Ilea A; Băbţan AM; Boşca BA; Crişan M; Petrescu NB; Collino M; Sainz RM; Gerlach JQ; Câmpian RS
    Arch Oral Biol; 2018 Sep; 93():22-30. PubMed ID: 29803117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases.
    Byun K; Yoo Y; Son M; Lee J; Jeong GB; Park YM; Salekdeh GH; Lee B
    Pharmacol Ther; 2017 Sep; 177():44-55. PubMed ID: 28223234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The false alarm hypothesis: Food allergy is associated with high dietary advanced glycation end-products and proglycating dietary sugars that mimic alarmins.
    Smith PK; Masilamani M; Li XM; Sampson HA
    J Allergy Clin Immunol; 2017 Feb; 139(2):429-437. PubMed ID: 27544741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Glycation Angle to Look into the Diabetic Vasculopathy: Cause and Cure.
    Ahmad S; Siddiqui Z; Rehman S; Khan MY; Khan H; Khanum S; Alouffi S; Saeed M
    Curr Vasc Pharmacol; 2017; 15(4):352-364. PubMed ID: 28356033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.
    Reynaert NL; Gopal P; Rutten EPA; Wouters EFM; Schalkwijk CG
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):403-418. PubMed ID: 27373680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do all roads lead to the Rome? The glycation perspective!
    Ahmad S; Akhter F; Shahab U; Rafi Z; Khan MS; Nabi R; Khan MS; Ahmad K; Ashraf JM; Moinuddin
    Semin Cancer Biol; 2018 Apr; 49():9-19. PubMed ID: 29113952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive skin autofluorescence, blood and urine assays of the advanced glycation end product (AGE) pentosidine as an indirect indicator of AGE content in human bone.
    Kida Y; Saito M; Shinohara A; Soshi S; Marumo K
    BMC Musculoskelet Disord; 2019 Dec; 20(1):627. PubMed ID: 31881872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.
    Valencia JV; Weldon SC; Quinn D; Kiers GH; DeGroot J; TeKoppele JM; Hughes TE
    Anal Biochem; 2004 Jan; 324(1):68-78. PubMed ID: 14654047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycative stress from advanced glycation end products (AGEs) and dicarbonyls: An emerging biological factor in cancer onset and progression.
    Lin JA; Wu CH; Lu CC; Hsia SM; Yen GC
    Mol Nutr Food Res; 2016 Aug; 60(8):1850-64. PubMed ID: 26774083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of advanced glycation end products in human infertility.
    Zhu JL; Cai YQ; Long SL; Chen Z; Mo ZC
    Life Sci; 2020 Aug; 255():117830. PubMed ID: 32450172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of advanced glycation end products (AGEs) signaling in coronary artery disease.
    Kosmopoulos M; Drekolias D; Zavras PD; Piperi C; Papavassiliou AG
    Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):611-619. PubMed ID: 30611860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Advanced Glycation Endproduct (AGE)-Receptor for Advanced Glycation Endproduct (RAGE) Axis in Cardiovascular Disease and Its Therapeutic Intervention.
    Yamagishi SI
    Circ J; 2019 Aug; 83(9):1822-1828. PubMed ID: 31366777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.